Page 7 - Crispr News Today

RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.

High costs and the complexity of administering the drugs may keep them out of reach of patients in need

The future of medicine could lie in gene editing, and researchers at Rensselaer Polytechnic Institute are at the forefront of it.This work inside an RPI lab is

Scientists have found a biological hack to keep French fries golden and tastier, addressing the issue of them turning dark and bitter.

Pigs that have been given genetically engineered immunity to porcine reproductive and respiratory syndrome, a major and costly disease, could be on the market within two years

Uruguay adopts CRISPR technology for a groundbreaking approach to combat screwworms from attacking cattle.

InnovationRx is your weekly digest of healthcare news. Sign up!

CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene therapy and beyond.

The decision comes after Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy was approved in the UK and US for sickle cell disease and beta thalassemia.

With the approval of CRISPR gene editing for sickle cell, could CRISPR be used for other diseases? Learn about five conditions CRISPR could treat.